DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Fosamax Plus D (Alendronate Sodium / Cholecalciferol) - Current Clinical Trials


Fosamax Plus D Related Clinical Trials

FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267) [Completed]

The Effects of Alendronate After Cure of Primary Hyperparathyroidism [Withdrawn]

Pilot Study of Fosamax in Spinal Cord Injury [Terminated]

Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions [Completed]

Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury Previously Treated With Teriparatide [Enrolling by invitation]

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss [Not yet recruiting]

Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263) [Completed]

Alendronate in Juvenile Osteoporosis [Completed]

Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients [Completed]

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis [Completed]

Parathyroid Hormone (PTH) With Alendronate for Osteoporosis [Completed]

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions. [Completed]

A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) [Completed]

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation [Active, not recruiting]

Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women [Completed]

Alendronate Compared to Metformin in Chronic Periodontitis [Completed]

A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) [Completed]

The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss [Completed]

A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)(COMPLETED) [Completed]

Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis [Completed]

Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050) [Withdrawn]

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults [Active, not recruiting]

Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment [Recruiting]

Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329) [Completed]

Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg) [Completed]

Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg) [Completed]

Safety and Effectiveness of Oral Alendronate Therapy on Bone Mineral Density in HIV-infected Children and Adolescents With Low Bone Mineral Density [Active, not recruiting]

Fosamax for Childhood Cancer Survivors [Recruiting]

Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants [Active, not recruiting]

Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease [Completed]

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density [Completed]

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) [Terminated]

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis [Completed]

A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D [Completed]

Testosterone and Alendronate in Hypogonadal Men [Recruiting]

Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis [Completed]

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose [Completed]

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Decreased Bone Mineral Density [Not yet recruiting]

Biorest Liposomal Alendronate With Stenting sTudy (BLAST) [Active, not recruiting]

Osteoporosis Prevention With Low Dose Alendronate [Completed]

Denosumab Adherence Preference Satisfaction Study [Completed]

Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate [Completed]

RA Denosumab on Bone Microstructure Study [Completed]

Treatment of Low Bone Density in Cystic Fibrosis. [Completed]

PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis [Completed]

Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment [Completed]

Sodium Alendronate in Non Surgical Periodontal Therapy [Completed]

Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss [Completed]

The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM) [Terminated]

Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate [Completed]

Alendronate for Vascular Calcification in Peritoneal Dialysis Patients? [Not yet recruiting]

Alendronate and/or Parathyroid Hormone for Osteoporosis [Completed]

Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS) [Active, not recruiting]

Study of Transitioning From Alendronate to Denosumab [Completed]

MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) [Completed]

The Forteo Alendronate Comparator Trial [Completed]

Alendronate to Prevent Loss of Bronchoprotection in Asthma [Recruiting]

Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients? [Completed]

1% Alendronate Gel in Treatment of Chronic Periodontitis Among Smokers [Completed]

Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density [Completed]

Comparison of Alendronate With Atorvastatin in Chronic Periodontitis [Completed]

Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis [Completed]

Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis [Active, not recruiting]

Treatment of Childhood Osteoporosis With Alendronate (Fosamax) [Completed]

Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis [Terminated]

Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta [Completed]

Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis [Completed]

Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial [Recruiting]

Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome [Completed]

Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120) [Completed]

Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. [Completed]

A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density. [Completed]

Upper GI Handling of Branded vs. Generic Alendronate [Completed]

Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy [Recruiting]

Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis. [Recruiting]

Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis [Completed]

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women [Completed]

Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism [Completed]

The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients [Completed]

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer [Terminated]

Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly [Recruiting]

A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. [Completed]

The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA) [Active, not recruiting]

Glucocorticoids Promote Osteoclast Survival [Terminated]

The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture. [Recruiting]

A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis [Completed]

Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment [Completed]

Osteoporosis and Dental Implant [Recruiting]

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) [Completed]

A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED) [Completed]

Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy [Terminated]

4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230) [Completed]

Transition From Alendronate to AMG 785 [Completed]

A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) [Completed]

Osteoporosis Prevention After Heart Transplant [Completed]

Cyclic Versus Daily Teriparatide on Bone Mass [Active, not recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017